GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » PB Ratio

Avricore Health (Avricore Health) PB Ratio : 7.46 (As of May. 30, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-30), Avricore Health's share price is $0.11185. Avricore Health's Book Value per Share for the quarter that ended in Dec. 2023 was $0.02. Hence, Avricore Health's PB Ratio of today is 7.46.

The historical rank and industry rank for Avricore Health's PB Ratio or its related term are showing as below:

AVCRF' s PB Ratio Range Over the Past 10 Years
Min: 1.19   Med: 5.71   Max: 20
Current: 7.75

During the past 13 years, Avricore Health's highest PB Ratio was 20.00. The lowest was 1.19. And the median was 5.71.

AVCRF's PB Ratio is ranked worse than
89.71% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.095 vs AVCRF: 7.75

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Avricore Health was 64.50% per year. The lowest was -55.10% per year. And the median was -12.00% per year.

Back to Basics: PB Ratio


Avricore Health PB Ratio Historical Data

The historical data trend for Avricore Health's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health PB Ratio Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 6.88 15.00 7.33

Avricore Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.75 15.00 13.66 12.51 7.33

Competitive Comparison of Avricore Health's PB Ratio

For the Diagnostics & Research subindustry, Avricore Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's PB Ratio distribution charts can be found below:

* The bar in red indicates where Avricore Health's PB Ratio falls into.



Avricore Health PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Avricore Health's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.11185/0.015
=7.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Avricore Health  (OTCPK:AVCRF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Avricore Health PB Ratio Related Terms

Thank you for viewing the detailed overview of Avricore Health's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (Avricore Health) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (Avricore Health) Headlines

From GuruFocus

VANC Announces Agreement for Acquisition of Corozon Platform

By GlobeNewswire GlobeNewswire 04-12-2018

VANC Pharmaceuticals Inc. Provides Corporate Update

By GlobeNewswire GlobeNewswire 11-02-2018

Avricore Grants Options

By GlobeNewswire GlobeNewswire 08-11-2022

Avricore Health Extends Closing of Placement

By GlobeNewswire GlobeNewswire 07-20-2019

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018